Mrs. Colleen Marie Holle, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 733 N. Main Street, Suite G, Bellevue, ID 83313 Phone: 208-725-3680 Fax: 208-595-2276 |
News Archive
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.
Par Pharmaceutical Companies, Inc. announced today that it has completed the acquisition of privately-held Edict Pharmaceuticals Private Limited, an India-based developer and manufacturer of generic pharmaceuticals.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 national research and training grants totaling $46,633,000 to 70 institutions nationwide in the first of two grants cycles for 2011.
In a post in the State Department's "DipNote" blog, Krysten Carrera, a Presidential Management fellow at the National Cancer Institute currently serving in the Bureau of International Organization Affairs, discusses "the growing international effort to address the threat of chronic non-communicable diseases."
› Verified 3 days ago